This website uses cookies
Read our Privacy policy and Terms of use for more information.
May 13, 2026
The updated system combines the hybrid-patch pump with the new DBLG2 algorithm and the Dexcom G7 CGM with commercial launch expected for this summer.
May 12, 2026
With CE Mark approval, Diabeloop's DBLG2 now integrates with the Kaleido pump and Dexcom G7.
May 11, 2026
Tandem Diabetes' first tubeless insulin pump could reach the market by the end of 2026, creating an entirely new category of insulin pump.
May 4, 2026
Breaking down how the system works with the setup, daily use, algorithm performance, and how it compares to DIY Loop and Omnipod systems.
Apr 27, 2026
Tandem's Control IQ+ becomes the only commercially available automated insulin delivery system approved for pregnancy use in the U.S.
Apr 23, 2026
The FDA has classified the Tandem Mobi insulin pump recall as Class I after a malfunction was found to disrupt insulin delivery and CGM communication.
Apr 9, 2026
Modular Medical's two-part tubeless patch design targets "almost-pumpers," with a planned U.S. commercial launch in Q2 2026.
Apr 6, 2026
The MiniMed Fit wear study is testing adhesive performance across body locations as the device moves closer to commercialization.
The latest integration marks the first time an implantable continuous glucose monitor has been used to automate insulin delivery with a pump.
